靶向治疗erbb2阳性转移性乳腺癌——我们应该“全力以赴”吗?

{"title":"靶向治疗erbb2阳性转移性乳腺癌——我们应该“全力以赴”吗?","authors":"P. Tarantino, H. Parsons, S. Tolaney","doi":"10.1001/jamaoncol.2022.1922","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":22.5000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go \\\"All In\\\"?-Reply.\",\"authors\":\"P. Tarantino, H. Parsons, S. Tolaney\",\"doi\":\"10.1001/jamaoncol.2022.1922\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14850,\"journal\":{\"name\":\"JAMA Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":22.5000,\"publicationDate\":\"2022-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamaoncol.2022.1922\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaoncol.2022.1922","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}